2Seventy Bio's earnings of $0.17 fell short of expectations, and profits were also lower than anticipated.

According to the 2Seventy Bio (NASDAQ: TSVT) report, the earnings per share for the fourth quarter was -$0.370, which is $0.17 worse than analysts' expectations of -$0.200. The reported profit for this quarter was set at $2.93 million, while analyst expectations were at $13.32 million.

2Seventy Bio shares closed the day at $4.95, reflecting a staggering 62,300% gain over the last three months, though the stock has decreased by 0.200% over the past year. While 2Seventy Bio saw positive earnings per share in the last 90 days, it also experienced negative earnings per share. Explore how 2Seventy Bio's stock price reacted to past earnings reports. According to InvestingPro, the company's financial health score is rated as "Fairly Good." Check out the latest earnings reports and all financial information on 2Seventy Bio. Stay updated on balance sheet developments by visiting the Investing.com Earnings Calendar.